Med. praxi. 2025;22(2):141-146 | DOI: 10.36290/med.2025.030
The article discusses systemic enzyme therapy (SET) to place it in the context of treating inflammatory diseases, clinical evidence of the preparation Phlogenzym, and the possibilities of its use. SET is a therapeutic modality based on the administration of proteolytic enzymes necessary for the optimal course of the inflammatory reaction. It therefore finds its place in the treatment of diseases caused or accompanied by both infectious and non-infectious inflammation. The two basic mechanisms of action include a direct proteolytic action and an immunomodulatory effect. Unlike anti-inflammatory drugs, SET does not affect the physiological extent of inflammation but accelerates its course, shortens recovery time, and reduces the frequency of recidivism. The clinical effectiveness of SET is documented by randomized controlled trials in different groups of patients.
Received: March 11, 2025; Revised: April 22, 2025; Accepted: April 22, 2025; Published: April 30, 2025 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...